![Matthew Korenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Korenberg
Director/Board Member at
PFENEX INC.
Net worth: 469 694 $ as of 2026-05-30
Profile
Matthew Edward Korenberg was the founder of Neurocircuit Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer & Director.
Current jobs include Director at Qualigen, Inc.; Director at The Pelican, Inc. since 2020; Director at Ligand UK Group Ltd. since 2018; Independent Director at Lifecore Biomedical, Inc. since 2024; and Chief Financial Officer, Secretary & Treasurer at Palvella Therapeutics, Inc. since 2024.
Former jobs include Director at Ligand UK Ltd.; Managing Director at Goldman Sachs & Co. LLC.
from 1999 to 2013; Independent Director at AIxCrypto Holdings, Inc. from 2020 to 2024; Director at Ligand UK Research Ltd.; and President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2022 to 2024.
Education includes undergraduate studies at the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-03 | 69,967 ( 0.19% ) | 351 234 $ | 2026-05-30 | |
0.01% | 2026-06-11 | 1,000 ( 0.01% ) | 118 460 $ | 2026-05-30 |
Matthew Korenberg active positions
| Companies | Position | Start |
|---|---|---|
| PFENEX INC. | Director/Board Member | 2020-09-30 |
| LIFECORE BIOMEDICAL, INC. | Director/Board Member | 2024-07-31 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2018-10-11 |
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Director/Board Member | - |
Former positions of Matthew Korenberg
| Companies | Position | End |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | President | 2024-10-30 |
| AIXCRYPTO HOLDINGS, INC. | Director/Board Member | 2024-10-02 |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Board Member | 2024-03-18 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2013-07-31 |
| VERNALIS | Director/Board Member | - |
Training of Matthew Korenberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Neurocircuit Therapeutics, Inc. | |
Qualigen Therapeutics, Inc.
 Qualigen Therapeutics, Inc. Packaged SoftwareTechnology Services Develops global ecosystem platform that integrates AI and blockchain systems to connect web apps | Technology Services |
- Stock Market
- Insiders
- Matthew Korenberg
Choose MarketScreener 
